Few case-finding instruments are available to community healthcare professionals. This review aims to identify short, valid instruments that detect older community-dwellers risk of four adverse outcomes: hospitalisation, functional-decline, institutionalisation and death. Data sources included PubMed and the Cochrane library. Data on outcome measures, patient and instrument characteristics, and trial quality (using the Quality In Prognosis Studies [QUIPS] tool), were double-extracted for derivation-validation studies in community-dwelling older adults (>50 years). Forty-six publications, representing 23 unique instruments, were included. Only five were externally validated. Mean patient age range was 64.2-84.6 years. Most instruments n = 18, (78%) were derived in North America from secondary analysis of survey data. The majority n = 12, (52%), measured more than one outcome with hospitalisation and the Probability of Repeated Admission score the most studied outcome and instrument respectively. All instruments incorporated multiple predictors. Activities of daily living n = 16, (70%), was included most often. Accuracy varied according to instruments and outcomes; area under the curve of 0.60-0.73 for hospitalisation, 0.63-0.78 for functional decline, 0.70-0.74 for institutionalisation and 0.56-0.82 for death. The QUIPS tool showed that 5/23 instruments had low potential for bias across all domains. This review highlights the present need to develop short, reliable, valid instruments to case-find older adults at risk in the community.
Introduction
As the proportion of older adults in the European Union increases [1] , healthcare delivery must be made more efficient to manage the consequences of chronic disease and disability. Older adults are more likely to experience adverse healthcare outcomes including hospitalisation [2] , institutionalisation [3] , and death [4] . Limited time, personnel, and resources require healthcare professionals to prioritise delivery of care. Prognostication is important to personalise care for older adults. One approach is to use riskprediction models, to measure risk of adverse outcomes, i.e. the chance that an event will occur in the future. Once quantified, individuals can be screened and triaged to receive targeted interventions [5] .
The European Innovation Partnership on Active and Healthy Ageing (EIP on AHA) is a multi-stakeholder collaboration across policies, sectors and borders in place to speed up innovations addressing the challenges associated with societal ageing. The EIP on AHAs' action plan A3, concerning the prevention and early diagnosis of frailty and functional decline in older people [6] , states that successful prevention of functional decline requires more knowledge about risk factors and the stratification of patients is key. Short risk-prediction instruments are useful to measure specific outcomes and identify high-risk individuals. Some instruments attempt to predict composite outcomes, while others focus on specific conditions [7] or adverse events such as hospitalisation [8] . Prediction models usually combine multiple, weighted predictors, and valid instruments should adequately report patient characteristics, attrition, outcomes and confounders [9, 10] . Care must be taken to ensure that these instruments are sufficiently accurate and reliable to avoid misdiagnosis and resulting harm [11] .
While a wide variety of instruments are available, their psychometric properties, including reliability, validity, and interpretability vary, with no single tool suggested to be acceptable across all settings [12] . While most older adults live in the community, most risk prediction instruments are designed for use in hospitalised older adults, who have higher levels of comorbidity [13] . Currently, there is little evidence for the utility of risk-prediction instruments in the community, with many studies excluding cohorts screened in this setting [12] . Existing systematic reviews have included inpatients; young (<50 years) and older patients; have concentrated on single outcomes, most often hospital re-admission; and have included short screening instruments and more complex algorithms based upon administrative "big" data [14, 15] .
The objective of this review was to investigate the availability and scope of short risk-prediction instruments, exclusively in community-dwelling older adults (>50 years), for a range of important adverse healthcare outcomes: hospitalisation, functional decline, institutionalisation and death. This review will also address whether these instruments have adequate psychometric properties to allow community healthcare professionals to casefind patients for more detailed assessment in clinical practice.
Methods

Search strategy
A literature search was conducted in scholarly databases (PubMed and the Cochrane Library). Reference lists of relevant papers or book chapters were also searched. The search included all available papers published between 1965 and November 2014. Each database was searched for all available articles describing short screening instruments in community-dwelling older adults (aged over 50) using the search terms: "screening" OR "screen" OR "instrument" OR "tool" OR "prediction model", OR "sensitivity" OR "specificity" OR "accuracy", AND "hospitalisation" OR "readmission" OR "functional decline" OR "institutionalisation" OR "death" AND "community" OR "home" AND "geriatric" OR "older" OR "older adult" OR "older person" OR "elderly". The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were followed in this systematic review [16] .
Data extraction
The titles and abstracts of the selected articles were screened for the inclusion criteria listed below and full articles retrieved, if relevant (by ROC and ROS). Of the 4479 abstracts retrieved from the searches, 451 full papers were retrieved from the pearling. Two independent reviewers (ROC and D.WM) extracted descriptive information on study populations, predictors, psychometric properties (criterion validity, defined as the accuracy of instruments to predict their intended outcomes, inter-rater reliability [IRR], test-retest reliability [TRT] and internal consistency [e.g. with Cronbach's alpha]), and outcomes from the selected papers.
Inclusion criteria
Papers were identified for inclusion based on the following criteria:
(i) Reported on a single short case finding risk-prediction instrument (including a screen or index accommodation (assisted living/supportive housing programmes), continuing care, retirement communities, or home-care were regarded as community-dwellers. Hospitalisation was defined as an unplanned admission to an acute (secondary or tertiary referral) hospital, not including elective admissions or planned rehabilitation or readmission within 30 days of discharge, the most common timeline for measuring re-hospitalisation [17] . Functional decline, defined as a disability or physical function limitation [18] , was included as an outcome measure if decline was recorded objectively by an established measure of activities of daily living (ADL). Death was included as an "extreme" functional decline where a composite measure of death or disability was included [19] . Only non-disease specific instruments were considered. In addition, studies reporting (i) complex computerised risk-prediction algorithms such as those predicting hospitalisation or hospital readmission [14] , (ii) predictors without developing an identifiable instrument, and (iii) measures of specific medical conditions or functional states including frailty, were excluded. Papers were most often excluded because they pertained to trial interventions rather than exploring the utility of specific instruments (n = 91), they pertained to other specific measures (n = 84) including frailty (n = 51) or they reported only the identification of predictors (n = 62). Fig. 1 presents a PRISMA flow diagram detailing reasons for exclusion.
Quality assessment
Quality assessment was performed by two independent raters (EW and NC), using the Quality in Prognosis Studies Tool (QUIPS) [9] , that identifies potential bias in studies reporting prognostic factors and instruments, in one of six domains: study participation, attrition prognostic factor measurement, outcome measurement, confounding and statistical analysis and reporting. The QUIPS was chosen as it is recommended by the authors of the CHecklist for critical Appraisal and data extraction for systematic Reviews of prediction Modelling Studies (CHARMS) checklist [20] as a measure of bias in prognostic instruments.
Results
Of the 451 papers reviewed, 46 met the inclusion criteria. From this, 23 unique, short risk-prediction instruments were deemed relevant and included in this review (see Fig. 1 ). The remaining articles described the external validation or the use of a selected instrument as an outcome measure. The sample was heterogeneous, in terms of setting, sample, data collection methods, instrument format, psychometric properties and healthcare outcomes measured. The characteristics and properties of each of the instruments included are presented in Table 1 .
In total, 18 instruments were originally derived and internally validated in North America (14 in the United States [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] , four in Canada [35] [36] [37] [38] ); four in Europe (one from Ireland [39, 40] , Italy [41] , the United Kingdom [42] and the Netherlands [19] ); and one in New Zealand [43] . Only five instruments: the Probability of Repeated Admission (Pra TM ) score [8] , Community Assessment Risk Screen (CARS) [44] , the Sherbrooke Postal Questionnaire (SPQ) [45, 46] , the Vulnerable Elderly Survey (VES-13) [47, 48] and a five year mortality index [49] , were externally validated. The most widely studied instrument, with nine validation studies and one systematic review available [8] was the Pra TM , measuring future risk of hospitalisation.
Patient characteristics
The demographic details of participants, reported in the initial derivation-validation study of each instrument, are presented in Table 2 . The mean age of participants across studies was 76.6 years, Please cite this article in press as: O'Caoimh R, et al. Risk prediction in the community: A systematic review of case-finding instruments that predict adverse healthcare outcomes in community-dwelling older adults. Maturitas (2015), http://dx.doi.org/10.1016/j.maturitas.2015.03.009 Table 1 Characteristics and properties of risk-prediction screens used for identifying adverse outcomes in community-dwelling older adults including hospitalisation or readmission, functional decline, institutionalisation, and death. Please cite this article in press as: O'Caoimh R, et al. Risk prediction in the community: A systematic review of case-finding instruments that predict adverse healthcare outcomes in community-dwelling older adults. Maturitas (2015), http://dx.doi.org/10.1016/j.maturitas.2015.03.009 Please cite this article in press as: O'Caoimh R, et al. Risk prediction in the community: A systematic review of case-finding instruments that predict adverse healthcare outcomes in community-dwelling older adults. Maturitas (2015), http://dx.doi.org/10.1016/j.maturitas.2015.03.009 Table 2 Demographic characteristics (age, gender, proportion living alone in the initial validation study) of community-dwelling older adults screened using short risk-prediction instruments including outcome measures assessed in all available studies (NR = not reported).
Instrument
Number [26] to 84.6 years [22] . Apart from one study [25] , the majority of participants were female, average 57.7%; the percentage of women included ranged from 3.2% [25] to 76% [32] . The percentage living alone ranged from 17.4% [41] to 47.4% [39, 40] and was reported for eight of the 23 original derivation-validation studies. There was inconsistent reporting of other baseline demographic details between studies. Sample sizes of both derivation and validation cohorts varied between studies.
Instrument characteristics
The majority (12/23, 52%), of the selected instruments measured more than one outcome, the most frequent being risk of hospitalisation (n = 14). Seven instruments predicted functional decline, five addressed the risk of institutionalisation and 12 predicted patient mortality. The most frequent single outcome measured was death (5/23). Only one instrument, the Geriatric Postal Screening Survey, reported all four outcomes of interest, in either the initial derivation-validation paper or subsequent external validation studies [25] . Prediction time varied according to outcomes and whether the study was reporting the internal or external validation of the instrument. Times ranged from 4.5 months [22] up to four years [21] for hospitalisation, one to five [28, 47] years for functional decline, one [25, 40] to five [37] years for institutionalisation and between six months [34] and five to nine years [33, 49] for risk of death.
The most common format for scoring the instrument was rater-administered questionnaires or indices derived through retrospective analysis of administrative or interview data from existing population surveys n = 13, (57%). The rest used selfadministered 'surveys' n = 10, (43%), usually delivered by post n = 6, (26%). The instruments were derived from patients either enrolled in longitudinal studies n = 8, (35%), included in healthcare registries n = 4, (17%), or sampled directly from those registered with their primary care physician, public health nurse or day centre n = 11, (48%). Almost half of the 18 studies derived in North America included patients enrolled in existing clinical studies n = 8, (44%) compared to none outside of the USA or Canada.
All instruments included multiple predictor variables, their distribution is presented in Table 3 . These ranged from three (CARS) [23] to 13 items (VES-13) [28] . The most frequently incorporated predictors were medical comorbidities (n = 15) and impairments in ADLs (n = 16). Others included age (n = 10), self-rated quality of life (QOL) (n = 9) and previous recent healthcare utilisation (n = 9). Gender, usually male sex, was included in seven instruments, five of which exclusively measured risk of death. Only seven studies incorporated the direct or indirect influence of a caregiver [21, 27, [34] [35] [36] 38, 40] . Medications were only scored for five instruments, all predicting risk of hospitalisation [23] [24] [25] [26] 36] .
Details of administration times were only provided for three of the instruments, each reported to be between 3 and 5 min [28, 39, 50] . The accuracy of screening tests, as measured by the area under the curve (AUC) of receiver operating characteristic curves, ranged from an AUC of 0.60-0.73 for hospitalisation to 0.63-0.78 for functional decline, 0.70-0.74 for institutionalisation and 0.56-0.82 for death. Ten instruments measuring risk of hospitalisation reported AUC values; three of which were greater than 0.7. None were greater than 0.8, the value considered for good to excellent accuracy [51] . Seven of the nine measures predicting death had an AUC of >0.70. Only one instrument, an index measuring four year risk of death [31] , had an AUC >0.8. Cut-off scores, to identify high-risk patients, were reported for just over half of the instruments (13/23, 57%). IRR and TRT reliability were inconsistently reported. Internal consistency was reported for only two instruments [40, 43] in the Community (RISC) reporting an ˛ > 0.9, suggesting excellent internal consistency.
Quality assessment
The methodological quality of the selected instruments, assessed using the QUIPS tool [9] , is presented in Table 4 . In all, five studies showed a low risk of bias for each of the six QUIPS domains. Five studies showed a moderate-to-high risk of bias in two or more domains; three showed moderate-to-high risk in four domains. All 23 instruments showed low bias for the study participation domain. Risk of bias was highest for the 'study confounding' (nine studies scoring moderate-high) and the 'study attrition' (12 studies scoring moderate-high) domains.
Discussion
This systematic review identifies the characteristics of validated, short, risk-prediction instruments that allow healthcare professionals case-find community-dwelling older adults at risk of four important adverse healthcare outcomes: hospitalisation, functional decline, institutionalisation and death. In total, 23 unique risk-prediction instruments were included. Few instruments were designed to measure single outcomes. More than half were validated to predict multiple or composite outcomes. Many potentially useful instruments were excluded because they are not yet validated in community settings. Most of those excluded were "situational" with an emphasis on screening on admission to hospital or pre-discharge, or designed to identify specific conditions such as frailty, nutritional deficiency or other functional states. Most of the 23 instruments selected for inclusion identified risk of hospitalisation, usually within one year of assessment. Few predicted risk of institutionalisation.
Most instruments were initially derived and validated in North America and approximately half were validated by retrospective analysis of data from patients enrolled in existing longitudinal studies. Indeed, the majority (57%) of instruments were derived in a similar fashion with the remainder developed in prospective patient cohorts, usually with questionnaires. Postal questionnaires have higher response rates than interview methods albeit with more missing values [52] . Only five of the 23 instruments were externally validated, a common criticism of current risk-prediction instruments [15] . Though most instruments appeared brief, few studies reported administration times. Short risk-prediction instruments, that usually function as screening tests, generally have poor accuracy [17] compared with more detailed, albeit less practical, algorithms using administrative "big" data [53] .
Most instruments had poor accuracy in predicting hospitalisation (AUC <0.70), particularly the CARS [23] , the RISC [40] , the Emergency Admission Risk Likelihood Index [42] and the instrument developed by Mazzaglia et al. [41] . This mirrors the results of a previous systematic review of risk prediction models for hospital readmission, scored during acute admissions, that found poor accuracy for many instruments, particularly among instruments derived using large administrative patient data [17] . The most widely validated short hospital prediction instrument was the Pra TM [14, 21] , suggesting that it had the greatest construct validity. A previous systematic review found that it performs adequately (composite AUC of 0.7), in predicting hospitalisation, particularly in high-risk individuals [8] . Higher accuracy was found for functional decline, institutionalisation and death. Accuracy for predicting death was higher than for hospitalisation including in studies reporting both outcomes [40, 41] . There was poor reporting of all measures of reliability, as reflected by the small number (five) of derivation papers showing a low risk of bias for all six QUIPS domains.
While several instruments were found that identify older community-dwellers at risk of functional decline and death, few instruments were available to predict institutionalisation. Baseline rates of institutionalisation are small however, 5-10% over three years, so studies are often underpowered to detect this outcome [54] . Given the high cost implications associated with institutionalisation [55] , as well as QOL implications [56] further research is needed to develop and validate instruments to accurately identify this outcome.
Identification of appropriate outcomes is central to developing accurate risk-prediction models. In this study there was considerable overlap in the variables incorporated in the different instruments, suggesting that instruments designed to measure one outcome may be valid in other settings. However, widely used tools may not always be suitable to convert, with additional factors such as usability, face validity, content validity and relevance of outcomes increasingly recognised as important [20] . Interactions between outcome measures are also complex with different adverse outcomes impacting upon each other such as risk of functional impairment and hospitalisation [57] . This review found that age, ADL, medical comorbidities, caregiver availability, selfrated health including QOL and recent healthcare utilisation were common predictors, irrespective of the outcomes that they were designed to predict. These factors should be considered in the future development of risk-prediction instruments to identify multiple adverse outcomes in community settings.
Limitations
One limitation was the deliberate exclusion of measures of frailty that, while often useful in predicting adverse outcomes, focus primarily on the measurement of frailty and are not always designed to measure specific healthcare outcomes. Excluding frailty screens may also explain the low number of instruments for measuring functional decline, many of which dated to a time before frailty was widely accepted as a clinical entity. This suggests that frailty may be a surrogate marker for risk and functional decline rather than a unique diagnostic entity. Frailty measures however, vary considerably, ranging from those scoring frailty risk factors to those identifying specific frailty phenotypes [7] , with some too impractical to use in community settings. Risk-prediction models for defined adverse healthcare outcomes often have greater accuracy when compared to frailty instruments [37, 39] . However, some short frailty screens and measures such as the Groningen Frailty Indicator and the VES-13 have been used as risk-prediction instruments and vice versa [7] . Likewise, there is considerable overlap in the predictors included in both types of instruments particularly mobility/physical activity, cognition and social support variables [7] . Thus, frailty and risk of adverse events including functional decline are not mutually exclusive and may in fact be measuring similar age-related healthcare outcomes. Other markers of adverse outcomes such as cognitive and nutritional scores were also excluded, further reducing the number of instruments available. This study was also limited by the heterogeneity of the validation cohorts that often differed in terms of follow-up periods and primary outcomes. Several of the risk-prediction models included were validated more than 20 years ago and maybe out-of-date. Despite this however, these instruments are precursors of modern risk and frailty measures, and have reasonable accuracy when modified and retrialled in modern healthcare systems [37] . Although this review excluded computerised risk-prediction algorithms using "big data", there is some evidence that these surrogates or proxies for short screens based upon this type of data have similar performance [35, 58] .
Please cite this article in press as: O'Caoimh R, et al. Risk prediction in the community: A systematic review of case-finding instruments that predict adverse healthcare outcomes in community-dwelling older adults. Maturitas (2015), http://dx.doi.org/10.1016/j.maturitas.2015.03.009 [43] Risk-prediction instruments are useful in clinical practice, often outperforming bias-prone clinician prognostication [59] . However, based upon this review, no single instrument can be recommended to predict adverse healthcare outcomes in community-dwelling older adults. Instead, this study suggests the need for researchers to incorporate predictor variables, common to all settings, into new, practical and acceptable short screening instruments, with the potential to detect multiple future adverse healthcare outcomes. Existing instruments show potential but further study is required including the demonstration of adequate psychometric properties and their external validation. Furthermore, it is important that all screening and case-finding instruments are not used in isolation but are instead integrated into holistic comprehensive assessment and management pathways to identify and treat community-dwelling older adults at risk [5, 11] .
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Conclusion
This review identifies the need to develop and validate short, reliable instruments, with evidence-based cut-offs, to identify community-dwelling older adults "at risk" for multiple potential adverse healthcare outcomes. Although heterogeneity was found in the samples and scoring methods in predicting outcomes, considerable overlap was found between the predictor variables and instrument accuracy. Most emphasis was on risk of hospitalisation or death with few instruments identifying risk of institutionalisation. Although five instruments had low bias on the QUIPS tool, no single, short, risk-prediction instrument can be recommended to screen older adults in the community. Future studies should seek to externally validate and compare risk-prediction instruments, contrast risk-prediction models with frailty measures, and compare rater versus self-administered measures, across different settings (community and hospital), for a broad range of adverse outcomes experienced by older adults in the community. 
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